Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Clinical Endocrinology|May 7, 2016
Effects of thyrotrophin, thyroid hormones and thyroid antibodies on metabolic parameters in a euthyroid population with obesitySule Temizkan, Bilgken Balaforlou, Aysenur Ozderya, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 8, 2014
Normocalcemic hyperparathyroidism and insulin resistanceSule Temizkan, Omer Kocak, Kadriye Aydin, et al.
Endocrine Journal|January 13, 2005
Prevalence of peripheral neuropathy in type 2 diabetic patients attending a diabetes center in TurkeyUlkü Türk Börü, Recep Alp, Haluk Sargin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 8, 2013
Risk of endocrine pancreatic insufficiency in patients receiving adjuvant chemoradiation for resected gastric cancerCengiz Gemici, Mehmet Sargin, Oya Uygur-Bayramicli, et al.
The Laryngoscope|December 25, 2015
Voice characteristics associated with polycystic ovary syndromeKadriye Aydin, Sevtap Akbulut, Mehmet Gokhan Demir, et al.
Clinical Rheumatology|January 20, 2016
Evaluation of acute and chronic MRI features of sacroiliitis in asymptomatic primary hyperparathyroid patientsMehmet Engin Tezcan, Sule Temizkan, Safiye Tokgoz Ozal, et al.
The Lancet. Diabetes & Endocrinology|April 8, 2017
Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trialBo Ahrén, Luis Masmiquel, Harish Kumar, et al.
World Journal of Gastroenterology|September 20, 2007
Type 2 diabetes mellitus and CA 19-9 levelsOya Uygur-Bayramicli, Resat Dabak, Ekrem Orbay, et al.
Diabetes Research and Clinical Practice|October 29, 2003
Comparison of lunch and bedtime NPH insulin plus mealtime insulin Lispro therapy with premeal regular insulin plus bedtime NPH insulin therapy in type 2 diabetesHaluk Sargin, Mehmet Sargin, Yüksel Altuntaş, et al.
World Journal of Gastroenterology|November 5, 2005
Is adiponectin level a predictor of nonalcoholic fatty liver disease in nondiabetic male patients?Haluk Sargin, Mehmet Sargin, Hülya Gozu, et al.
Pageof 7